Nasdaq:US$16.88 (-0.66) | HKEX:HK$26.60 (+0.00) | AIM:£2.70 (-0.13)
搜索结果
上一篇文章   |   下一篇文章
公告及新闻稿, 肿瘤学 / 免疫学 | 2006-07-04

Chi-Med plans to broaden clinical trials of its leading oncology drug candidate